Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to integrate steatotic liver disease indicators into non-communicable disease policy and frameworks to meet the World Health Assembly resolution on steatotic liver disease adopted in May 2026.

Answered by Sharon Hodgson

The Government recognises the importance of the World Health Assembly’s resolution on steatotic liver disease (SLD), which marks the first time liver disease has been formally recognised as part of the global agenda on noncommunicable diseases.

We are taking action to ensure SLD is integrated within whole-system approaches and tackled effectively. This includes through NHS England’s Liver Transformation Programme, which aims to improve liver disease diagnosis and treatment through focus on the entire care pathway, ensuring a more integrated and effective approach to liver care. The programme has three workstreams, awareness and prevention, detection and diagnosis, and treatment, which will ensure outcomes are aligned with the goals of the World Health Assembly’s resolution on SLD.

Furthermore, the newly published Cardiovascular Disease Modern Service Framework is specifically designed as an integrated cardiovascular-kidney-metabolic strategy and makes specific mention of the importance of addressing metabolic associated SLD.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of retiring the OHID Liver Disease Fingertips Profiles on the UK's ability to monitor steatotic liver disease indicators and meet the World Health Assembly resolution on steatotic liver disease adopted in May 2026.

Answered by Sharon Hodgson

The Office for Health Improvement and Disparities (OHID) continues to monitor a wide range of indicators relating to steatotic liver disease, an umbrella term that includes a range of conditions where fat accumulates in liver cells causing dysfunction. Indicators include liver disease and alcoholic liver disease mortality, alcoholic liver disease and alcoholic related hospital admissions, as well as population levels of associated risk factors, including alcohol consumption, obesity, physical activity, diet, and smoking, situated in different profiles on Fingertips. The indicators only cover England.

OHID ceased to update non-alcoholic fatty liver disease hospital admissions rates and premature deaths, in people aged under 75 years old, on the Fingertips profiles in December 2025, as the indicators were not accurate assessments of that condition and only monitored the most severe forms rather than prevalence, and the level of the disease in the population.

Retiring the liver disease profile therefore has had little impact on our ability to monitor steatotic liver disease.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will publish a Roadmap to a Smokefree country to ensure that areas like Blackpool and Fleetwood, where smoking rates are higher than the national average, can support every smoker who wants to quit.

Answered by Sharon Hodgson

The previous Government’s ambition was to reduce adult smoking prevalence to 5% or less by 2030. We are going even further. Our ambition is to deliver a smoke-free United Kingdom and the landmark Tobacco and Vapes Act will create the first smoke-free generation which is expected to help reduce smoking rates of 14 to 30-year-olds to near zero by 2050.

We fully recognise the importance of stopping people starting smoking, but also of supporting smokers to quit. Alongside the Tobacco and Vapes Act, we have ringfenced funding for stop smoking services within the Public Health Grant, protecting at least £153 million per year for these services. Funding is weighted towards areas with higher smoking prevalence, ensuring we are targeting support to those who need it most, ensuring no one is left behind.

Our immediate focus is on the successful implementation of the smoke-free generation policy and moving swiftly with the secondary legislation programme. We will continue to consider the benefits of publishing a smoke-free roadmap, balancing it against the importance of successfully implementing our significant legislative programme.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether smokefree 2030 remains his Department's target.

Answered by Sharon Hodgson

The previous Government’s ambition was to reduce adult smoking prevalence to 5% or less by 2030. We are going even further. Our ambition is to deliver a smoke-free United Kingdom and the landmark Tobacco and Vapes Act will create the first smoke-free generation which is expected to help reduce smoking rates of 14 to 30-year-olds to near zero by 2050.

We fully recognise the importance of stopping people starting smoking, but also of supporting smokers to quit. Alongside the Tobacco and Vapes Act, we have ringfenced funding for stop smoking services within the Public Health Grant, protecting at least £153 million per year for these services. Funding is weighted towards areas with higher smoking prevalence, ensuring we are targeting support to those who need it most, ensuring no one is left behind.

Our immediate focus is on the successful implementation of the smoke-free generation policy and moving swiftly with the secondary legislation programme. We will continue to consider the benefits of publishing a smoke-free roadmap, balancing it against the importance of successfully implementing our significant legislative programme.

Prohibiting Members of Parliament from having paid second jobs

Toxicity testing on animals

Higher Education pensions

Autonomy’s report entitled Cleaning Up Politics

Civil Service Pension Scheme

Bank holiday for celebrations if England win the 2026 FIFA World Cup

Found: In February 2026, a Parliamentary Question initiated by the MS Society in partnership with Lorraine Beavers